Guingona, Ester S.

HRN: 23-18-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
CEFTRIAXONE 1G (VIAL)
03/13/2026
03/20/2026
IV
2 Grams
OD
Lacerated Wound, Head; TBI
Pending Pharmacy Acceptance 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: